Oral Contraception: Beyond What Meets the Eye. Sorry, the Ovaries!

How Diversity, Equity and Inclusion are Changing Clinical Research

“…In cardiology, clinical presentation, risk stratification, prevention, treatment, and outcome parameters are gender sensitive, and this should be taken into account when designing clinical trials. 2 Recently, the American College of Cardiology's Cardiovascular Disease in Women Committee Leadership Council pointed out the low rates of women enrollment in cardiovascular research: the rates of women across coronary artery disease, acute coronary syndrome, and heart failure trials were 27.3%, 26.9% and 28,6%, respectively. 3 Sexspecific data concerning therapy is essential because women may respond differently than men and may even have adverse effects from some drugs at the same dosage that are beneficial to men.…”